ATE453380T1 - Verabreichung von in lipidvesikeln verpackten kleinen hydrophilen molekülen - Google Patents

Verabreichung von in lipidvesikeln verpackten kleinen hydrophilen molekülen

Info

Publication number
ATE453380T1
ATE453380T1 AT02743969T AT02743969T ATE453380T1 AT E453380 T1 ATE453380 T1 AT E453380T1 AT 02743969 T AT02743969 T AT 02743969T AT 02743969 T AT02743969 T AT 02743969T AT E453380 T1 ATE453380 T1 AT E453380T1
Authority
AT
Austria
Prior art keywords
administration
lipid vesicles
hydrophilic molecules
small hydrophilic
molecules packaged
Prior art date
Application number
AT02743969T
Other languages
English (en)
Inventor
Robert Friesen
Berend Poolman
Bernard Lucas Feringa
Jan Engberts
Original Assignee
Applied Nanosystems Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Nanosystems Bv filed Critical Applied Nanosystems Bv
Application granted granted Critical
Publication of ATE453380T1 publication Critical patent/ATE453380T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT02743969T 2001-06-21 2002-06-21 Verabreichung von in lipidvesikeln verpackten kleinen hydrophilen molekülen ATE453380T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01202401A EP1269993A1 (de) 2001-06-21 2001-06-21 Verabreichung von in Lipidvesikeln verpackten kleinen hydrophilen Molekülen
PCT/NL2002/000412 WO2003000233A2 (en) 2001-06-21 2002-06-21 Delivery of small hydrophilic molecules packaged into lipid vesicles

Publications (1)

Publication Number Publication Date
ATE453380T1 true ATE453380T1 (de) 2010-01-15

Family

ID=8180516

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02743969T ATE453380T1 (de) 2001-06-21 2002-06-21 Verabreichung von in lipidvesikeln verpackten kleinen hydrophilen molekülen

Country Status (7)

Country Link
US (1) US20030118636A1 (de)
EP (2) EP1269993A1 (de)
AT (1) ATE453380T1 (de)
CA (1) CA2451148A1 (de)
DE (1) DE60234921D1 (de)
DK (1) DK1397123T3 (de)
WO (1) WO2003000233A2 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1412487T3 (da) 2001-07-30 2010-08-30 Meso Scale Technologies Llc Assayelektroder der har immobiliserede lipid/proteinlag og fremgangsmåder til at fremstille og anvende disse
JP2005530704A (ja) * 2002-03-05 2005-10-13 トランセイブ， インク． 細胞内感染を予防及び治療するための吸入システム
EP3427742B1 (de) * 2002-10-29 2020-08-12 Insmed Incorporated Aminoglycosid enthaltende liposome zur behandlung von pulmonaren infektionen
US7718189B2 (en) 2002-10-29 2010-05-18 Transave, Inc. Sustained release of antiinfectives
US7879351B2 (en) * 2002-10-29 2011-02-01 Transave, Inc. High delivery rates for lipid based drug formulations, and methods of treatment thereof
US7968115B2 (en) * 2004-03-05 2011-06-28 Board Of Regents, The University Of Texas System Liposomal curcumin for treatment of cancer
US7459147B2 (en) 2003-06-30 2008-12-02 L'oreal Cosmetic composition comprising at least one hydrophilic organopolysiloxane, at least one hydrocarbon oil and at least one short hydrocarbon ester
US8784881B2 (en) * 2004-03-05 2014-07-22 Board Of Regents, The University Of Texas System Liposomal curcumin for treatment of diseases
US20080103213A1 (en) * 2004-03-05 2008-05-01 Board Of Regents, The University Of Texas System Liposomal curcumin for treatment of neurofibromatosis
ES2798263T3 (es) 2005-12-08 2020-12-10 Insmed Inc Composiciones a base de lípidos de antiinfecciosos para tratar infecciones pulmonares
US20100196455A1 (en) * 2007-05-04 2010-08-05 Transave, Inc. Compositions of Multicationic Drugs for Reducing Interactions with Polyanionic Biomolecules and Methods of Use Thereof
US9333214B2 (en) 2007-05-07 2016-05-10 Insmed Incorporated Method for treating pulmonary disorders with liposomal amikacin formulations
US9114081B2 (en) 2007-05-07 2015-08-25 Insmed Incorporated Methods of treating pulmonary disorders with liposomal amikacin formulations
US9119783B2 (en) 2007-05-07 2015-09-01 Insmed Incorporated Method of treating pulmonary disorders with liposomal amikacin formulations
US20100189777A1 (en) * 2007-07-20 2010-07-29 Basf Se Functionalized nanocompartments with a transport system
EP2127640A1 (de) 2008-05-27 2009-12-02 Koninklijke Philips Electronics N.V. Modifizierte azid-enthaltende Proteine
US9345113B2 (en) 2009-06-24 2016-05-17 Koninklijke Philips N.V. Method and device for programming a microcontroller
WO2011097480A1 (en) * 2010-02-05 2011-08-11 University Of Louisville Research Foundation, Inc. Exosomal compositions and methods for the treatment of disease
ES2905368T3 (es) 2012-05-21 2022-04-08 Insmed Inc Sistemas para el tratamiento de infecciones pulmonares
WO2014081300A1 (en) * 2012-11-22 2014-05-30 Tagworks Pharmaceuticals B.V. Channel protein activatable liposomes
WO2014085526A1 (en) 2012-11-29 2014-06-05 Insmed Incorporated Stabilized vancomycin formulations
KR102205278B1 (ko) 2013-03-14 2021-01-22 다이서나 파마수이티컬, 인크. 음이온성 약제를 제형화하는 방법
PL3142643T3 (pl) 2014-05-15 2019-12-31 Insmed Incorporated Sposoby leczenia zakażeń płuc prątkami niegruźliczymi
EP3773505A4 (de) 2018-03-30 2021-12-22 Insmed Incorporated Verfahren zur kontinuierlichen herstellung von liposomalen arzneimittelprodukten
AU2019262117C1 (en) 2018-05-02 2024-12-05 Insmed Incorporated Methods for the manufacture of liposomal drug formulations
WO2020112408A1 (en) * 2018-11-30 2020-06-04 Corning Incorporated System and method for analyzing extracellular vesicles with an optical biosensor

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4900556A (en) * 1985-04-26 1990-02-13 Massachusetts Institute Of Technology System for delayed and pulsed release of biologically active substances
US5252263A (en) * 1986-06-16 1993-10-12 The Liposome Company, Inc. Induction of asymmetry in vesicles
DE3852036T2 (de) * 1987-07-27 1995-03-09 Commonwealth Scientific And Industrial Research Organization, Campbell Rezeptormembranen.
US5227470A (en) * 1988-08-26 1993-07-13 Canon Kabushiki Kaisha Method for forming proteoliposome and method for forming giant proteoliposome
US5874316A (en) * 1989-01-27 1999-02-23 Australian Membrane Biotechnology Research Institute Receptor membranes and ionophore gating
EP0770874A3 (de) * 1989-01-27 1998-01-21 Australian Membrane And Biotechnology Research Institute Rezeptormembranen und selektive Steuerung des Ionenflusses durch Ionophoren
US5753258A (en) * 1990-10-19 1998-05-19 University Of Florida Artificial viral envelopes
US5252348A (en) * 1990-10-19 1993-10-12 Univ. Of Florida Research Foundation, Inc. Artificial viral envelopes
US5820879A (en) * 1993-02-12 1998-10-13 Access Pharmaceuticals, Inc. Method of delivering a lipid-coated condensed-phase microparticle composition
US5753261A (en) * 1993-02-12 1998-05-19 Access Pharmaceuticals, Inc. Lipid-coated condensed-phase microparticle composition
ES2177602T3 (es) * 1994-11-18 2002-12-16 Stichting Nl I Voor Zuivelonde Metodo para controlar la expresion de genes en acido lactico.
WO1999003889A1 (en) * 1997-07-15 1999-01-28 The Regents Of The University Of California Isolated dna encoding human calcium activated potassium channel
US6165732A (en) * 1997-10-14 2000-12-26 Washington University Method for identifying apoptosis modulating compounds
GB9721901D0 (en) * 1997-10-16 1997-12-17 Univ Manchester Particles

Also Published As

Publication number Publication date
DE60234921D1 (de) 2010-02-11
DK1397123T3 (da) 2010-05-03
CA2451148A1 (en) 2003-01-03
EP1397123A2 (de) 2004-03-17
EP1269993A1 (de) 2003-01-02
EP1397123B1 (de) 2009-12-30
WO2003000233A3 (en) 2003-10-16
US20030118636A1 (en) 2003-06-26
WO2003000233A2 (en) 2003-01-03

Similar Documents

Publication Publication Date Title
ATE453380T1 (de) Verabreichung von in lipidvesikeln verpackten kleinen hydrophilen molekülen
NO20001683L (no) Peptid/lipid-kompleksdannelse ved samlyofilisering
ATE263579T1 (de) Abgabe von polyethylene glycol-molekül- konjugaten aus abbaubarem hydrogel
ATE368054T1 (de) Verbindungen und methoden zur modulierung von occludin-abhängiger gewebepermeabilität
ATE322255T1 (de) Polyamid-oligomere
DK0909183T3 (da) DHA-konjugerede farmaceutisk midler
DE69508598D1 (de) Mit polyethylenglycol modifizierte ceramidlipide und liposomen
ATE223232T1 (de) Tocopherolzusammensetzungen zur abgabe von biologisch aktiven substanzen
ID27788A (id) Peptida-peptida antigen tumor yang diperoleh dari siklofilin b
EP1490483A4 (de) In-vivo-einbau von nicht in der natur vorkommenden aminosäuren
NO993257L (no) N-acylfosfatidyletanolaminformidlet liposomal legemiddelavlevering
ATE244015T1 (de) Formulierungen fuer faktor ix
ATE273320T1 (de) Fusogene liposomen
CY1105953T1 (el) Συνθεσεις για απελευθερωση συνδυασμων φαρμακων
NO990276L (no) Ultralydavbildning av lever
ES2216055T3 (es) Metodos para reducir o mantener niveles reducidos de lipidos en sangre usando composiciones de proteina ob.
CY1106886T1 (el) Πολυμερη προϊοντα συζευξης της neublastin και μεθοδοι χρησης αυτων
DE60126760D1 (de) Vektorkonstrukte
ATE252888T1 (de) Lipid haltige zusammenstellungen und deren verwendungen
ATE373466T1 (de) Lipidträgerzusammensetzungen und verfahren zur verbesserten wirkstoffzurückhaltung
ATE301709T1 (de) Lipidabkömmlinge von pentaerythritol
ATE345778T1 (de) (ester)-lysolecithine in liposomen
CY1106306T1 (el) Παραγωγα 5-ιμινο-13-δεοξυ ανθρακυκλινης, οι χρησεις τους και διepγασιες παρασκευης αυτων
TR199701225A2 (xx) Gen terapisi için katyonik lipidler.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties